Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest ARCH VENTURE CORP Stock Portfolio

$266Million– No. of Holdings #9

ARCH VENTURE CORP Performance:
2024 Q2: -8.1%YTD: -8.61%2023: -8.31%

Performance for 2024 Q2 is -8.1%, and YTD is -8.61%, and 2023 is -8.31%.

About ARCH VENTURE CORP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, ARCH Venture Management, LLC reported an equity portfolio of $266 Millions as of 30 Jun, 2024.

The top stock holdings of ARCH Venture Management, LLC are BEAM, , ERAS. The fund has invested 47.9% of it's portfolio in BEAM THERAPEUTICS INC. and 32.6% of portfolio in RAPPORT THERAPEUTICS, INC.

The fund managers got completely rid off DENALI THERAPEUTICS, INC. (DNLI) and SINGULAR GENOMICS SYSTEMS, INC. (OMIC) stocks. ARCH Venture Management, LLC opened new stock positions in BEAM THERAPEUTICS INC. (BEAM), RAPPORT THERAPEUTICS, INC. and SINGULAR GENOMICS SYSTEMS, INC. (OMIC).
ARCH VENTURE CORP Equity Portfolio Value
Last Reported on: 14 Aug, 2024

ARCH VENTURE CORP Annual Return Estimates Vs S&P 500

Our best estimate is that ARCH Venture Management, LLC made a return of -8.1% in the last quarter. In trailing 12 months, it's portfolio return was -16.09%.

New Buys

Ticker$ Bought
beam therapeutics inc.127,530,000
rapport therapeutics, inc.86,730,400
singular genomics systems, inc.1,070,020

New stocks bought by ARCH VENTURE CORP

Additions

No additions were made to existing positions by ARCH VENTURE CORP

Reductions

None of the existing positions were reduced by ARCH VENTURE CORP

Sold off

Ticker$ Sold
denali therapeutics, inc.-7,823,230
singular genomics systems, inc.-1,953,410

ARCH VENTURE CORP got rid off the above stocks

Sector Distribution

ARCH Venture Management, LLC has about 65.1% of it's holdings in Healthcare sector.

Sector%
Healthcare65.1
Others34.9

Market Cap. Distribution

ARCH Venture Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP47.9
UNALLOCATED34.9
SMALL-CAP13.5
MICRO-CAP2.7

Stocks belong to which Index?

About 61.4% of the stocks held by ARCH Venture Management, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200061.4
Others38.6
Top 5 Winners (%)%
OMIC
singular genomics systems, inc.
2012.5 %
ERAS
erasca, inc.
14.6 %
Top 5 Winners ($)$
ERAS
erasca, inc.
3.3 M
OMIC
singular genomics systems, inc.
1.0 M
Top 5 Losers (%)%
VERV
verve therapeutics, inc.
-63.3 %
GOSS
gossamer bio, inc.
-23.6 %
UBX
unity biotechnology, inc.
-17.7 %
BEAM
beam therapeutics inc.
-0.8 %
Top 5 Losers ($)$
VERV
verve therapeutics, inc.
-16.9 M
GOSS
gossamer bio, inc.
-2.2 M
BEAM
beam therapeutics inc.
-1.1 M
UBX
unity biotechnology, inc.
-0.3 M

ARCH VENTURE CORP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ARCH VENTURE CORP

ARCH Venture Management, LLC has 9 stocks in it's portfolio. VERV proved to be the most loss making stock for the portfolio. ERAS was the most profitable stock for ARCH Venture Management, LLC last quarter.

Last Reported on: 14 Aug, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions